These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1351680)

  • 1. Genotypic analysis of N-ethyl-N-nitrosourea-induced mutations by Taq I restriction fragment length polymorphism/polymerase chain reaction in the c-H-ras1 gene.
    Chiocca SM; Sandy MS; Cerutti PA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5331-5. PubMed ID: 1351680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic mutation analysis by RFLP/PCR.
    Pourzand C; Cerutti P
    Mutat Res; 1993 Jul; 288(1):113-21. PubMed ID: 7686255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic analysis of mutations in Taq I restriction recognition sites by restriction fragment length polymorphism/polymerase chain reaction.
    Sandy MS; Chiocca SM; Cerutti PA
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):890-4. PubMed ID: 1736304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genotypic mutation system measuring mutations in restriction recognition sequences.
    Felley-Bosco E; Pourzand C; Zijlstra J; Amstad P; Cerutti P
    Nucleic Acids Res; 1991 Jun; 19(11):2913-9. PubMed ID: 1676153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of H-ras codons 11 and 12 in human fibroblasts by N-ethyl-N-nitrosourea.
    Pourzand C; Cerutti P
    Carcinogenesis; 1993 Oct; 14(10):2193-6. PubMed ID: 8106179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis of codon 248 of the human p53 tumor suppressor gene by N-ethyl-N-nitrosourea.
    Hussain SP; Aguilar F; Cerutti P
    Oncogene; 1994 Jan; 9(1):13-8. PubMed ID: 7905619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to detect ras point mutations in small subpopulations of cells.
    Chen J; Viola MV
    Anal Biochem; 1991 May; 195(1):51-6. PubMed ID: 1679614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis using the restriction site mutation (RSM) assay.
    Jenkins GJ; Chaleshtori MH; Song H; Parry JM
    Mutat Res; 1998 Sep; 405(2):209-20. PubMed ID: 9748583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked differences in the role of O6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea.
    Jansen JG; Vrieling H; van Teijlingen CM; Mohn GR; Tates AD; van Zeeland AA
    Cancer Res; 1995 May; 55(9):1875-82. PubMed ID: 7728755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-phenotypic selection of N-methyl-N-nitrosourea-induced mutations in human cells.
    Palombo F; Bignami M; Dogliotti E
    Nucleic Acids Res; 1992 Mar; 20(6):1349-54. PubMed ID: 1348577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymerase chain reaction, cold probes and clinical diagnosis].
    Haras D; Amoros JP
    Sante; 1994; 4(1):43-52. PubMed ID: 7909267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase chain reaction amplification and sequence analysis of human mutant adenine phosphoribosyltransferase genes: the nature and frequency of errors caused by Taq DNA polymerase.
    Chen J; Sahota A; Stambrook PJ; Tischfield JA
    Mutat Res; 1991 Jul; 249(1):169-76. PubMed ID: 2067530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
    Huber S; McMaster KJ; Voelkerding KV
    J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient and optimized PCR method with high fidelity for site-directed mutagenesis.
    Liang Q; Chen L; Fulco AJ
    PCR Methods Appl; 1995 Apr; 4(5):269-74. PubMed ID: 7580913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide analogs and new buffers improve a generalized method to enrich for low abundance mutations.
    Day JP; Hammer RP; Bergstrom D; Barany F
    Nucleic Acids Res; 1999 Apr; 27(8):1819-27. PubMed ID: 10101189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and investigation of Campylobacter jejuni by polymerase chain reaction-restriction fragment length polymorphism analysis.
    Kiuchi A; Hara M; Pham HS; Takikawa K; Itoh R; Tabuchi K
    Microbios; 2000; 102(403):159-64. PubMed ID: 10955830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of mutation of a synthetic c-Ha-ras gene containing hypoxanthine.
    Kamiya H; Miura H; Kato H; Nishimura S; Ohtsuka E
    Cancer Res; 1992 Apr; 52(7):1836-9. PubMed ID: 1551113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient site-directed mutagenesis using polymerase chain reaction.
    Yang XJ; Chen CQ; Wang DB; Yang SL
    Sci China B; 1991 Jun; 34(6):712-8. PubMed ID: 1888438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.